NZ507641A

NZ507641A - Nk cell activation inducing ligand (nail) dna and polypeptides and use thereof

Nk cell activation inducing ligand (nail) dna and polypeptides and use thereof

Info

Publication number: NZ507641A
Authority: NZ; New Zealand
Prior art keywords: nail; cells; polypeptide; polypeptides; seq
Prior art date: 1998-03-27

Application number

NZ507641A

Other languages

English (en)

Inventor

Marek Z Kubin

Raymond G Goodwin

Original Assignee

Immunex Corp

Priority date

1998-03-27

Filing date

1999-03-23

Publication date

2003-09-26

1999-03-23 Application filed by Immunex Corp filed Critical Immunex Corp

2003-09-26 Publication of NZ507641A publication Critical patent/NZ507641A/en

Links

108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 527
102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 500
229920001184 polypeptide Polymers 0.000 title claims abstract description 462
101000884270 Homo sapiens Natural killer cell receptor 2B4 Proteins 0.000 title claims description 381
102100038082 Natural killer cell receptor 2B4 Human genes 0.000 title description 353
210000004027 cell Anatomy 0.000 claims abstract description 327
101000716130 Homo sapiens CD48 antigen Proteins 0.000 claims abstract description 205
102100036008 CD48 antigen Human genes 0.000 claims abstract description 197
230000027455 binding Effects 0.000 claims abstract description 125
210000000822 natural killer cell Anatomy 0.000 claims abstract description 124
238000000034 method Methods 0.000 claims abstract description 111
239000012634 fragment Substances 0.000 claims abstract description 100
108020004414 DNA Proteins 0.000 claims abstract description 76
150000007523 nucleic acids Chemical class 0.000 claims abstract description 49
125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 42
108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 40
108020004707 nucleic acids Proteins 0.000 claims abstract description 36
102000039446 nucleic acids Human genes 0.000 claims abstract description 36
239000002773 nucleotide Substances 0.000 claims abstract description 34
125000003729 nucleotide group Chemical group 0.000 claims abstract description 34
230000002401 inhibitory effect Effects 0.000 claims abstract description 15
206010028980 Neoplasm Diseases 0.000 claims abstract description 13
239000003112 inhibitor Substances 0.000 claims abstract description 11
201000011510 cancer Diseases 0.000 claims abstract description 10
230000035755 proliferation Effects 0.000 claims abstract description 9
238000012216 screening Methods 0.000 claims abstract description 9
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims abstract description 8
238000005406 washing Methods 0.000 claims abstract description 7
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims abstract 2
102000053602 DNA Human genes 0.000 claims abstract 2
150000001413 amino acids Chemical class 0.000 claims description 56
230000014509 gene expression Effects 0.000 claims description 55
108020001507 fusion proteins Proteins 0.000 claims description 37
102000037865 fusion proteins Human genes 0.000 claims description 36
239000000203 mixture Substances 0.000 claims description 32
210000003719 b-lymphocyte Anatomy 0.000 claims description 31
238000004519 manufacturing process Methods 0.000 claims description 30
230000000638 stimulation Effects 0.000 claims description 24
210000004443 dendritic cell Anatomy 0.000 claims description 23
239000003814 drug Substances 0.000 claims description 20
239000013598 vector Substances 0.000 claims description 20
230000004936 stimulating effect Effects 0.000 claims description 17
210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims description 15
239000000523 sample Substances 0.000 claims description 15
102000048338 human CD244 Human genes 0.000 claims description 10
230000028327 secretion Effects 0.000 claims description 9
108010065805 Interleukin-12 Proteins 0.000 claims description 8
102000013462 Interleukin-12 Human genes 0.000 claims description 8
108090000978 Interleukin-4 Proteins 0.000 claims description 8
102000046585 human CD48 Human genes 0.000 claims description 8
108010029697 CD40 Ligand Proteins 0.000 claims description 7
102100032937 CD40 ligand Human genes 0.000 claims description 7
239000002671 adjuvant Substances 0.000 claims description 7
238000012360 testing method Methods 0.000 claims description 7
102000003814 Interleukin-10 Human genes 0.000 claims description 6
230000020411 cell activation Effects 0.000 claims description 6
238000012258 culturing Methods 0.000 claims description 6
239000003085 diluting agent Substances 0.000 claims description 6
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
108090000174 Interleukin-10 Proteins 0.000 claims description 5
108700012920 TNF Proteins 0.000 claims description 5
108091033319 polynucleotide Proteins 0.000 claims description 5
102000040430 polynucleotide Human genes 0.000 claims description 5
239000002157 polynucleotide Substances 0.000 claims description 5
210000004962 mammalian cell Anatomy 0.000 claims description 4
239000000546 pharmaceutical excipient Substances 0.000 claims description 4
230000001737 promoting effect Effects 0.000 claims description 4
230000002163 immunogen Effects 0.000 claims description 3
150000001875 compounds Chemical class 0.000 claims description 2
239000000178 monomer Substances 0.000 claims description 2
229960005486 vaccine Drugs 0.000 claims description 2
239000012472 biological sample Substances 0.000 claims 2
101000608935 Homo sapiens Leukosialin Proteins 0.000 claims 1
102100039564 Leukosialin Human genes 0.000 claims 1
238000003158 yeast two-hybrid assay Methods 0.000 claims 1
239000003446 ligand Substances 0.000 abstract description 11
230000001939 inductive effect Effects 0.000 abstract description 5
239000012190 activator Substances 0.000 abstract description 2
108090000623 proteins and genes Proteins 0.000 description 147
102000004169 proteins and genes Human genes 0.000 description 113
235000018102 proteins Nutrition 0.000 description 107
235000011468 Albizia julibrissin Nutrition 0.000 description 73
241001070944 Mimosa Species 0.000 description 73
235000001014 amino acid Nutrition 0.000 description 44
229940024606 amino acid Drugs 0.000 description 43
210000001744 T-lymphocyte Anatomy 0.000 description 36
239000013604 expression vector Substances 0.000 description 36
239000002299 complementary DNA Substances 0.000 description 34
230000000694 effects Effects 0.000 description 32
108091034117 Oligonucleotide Proteins 0.000 description 29
108010076504 Protein Sorting Signals Proteins 0.000 description 29
230000004071 biological effect Effects 0.000 description 26
230000001404 mediated effect Effects 0.000 description 26
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 25
230000004913 activation Effects 0.000 description 25
238000003556 assay Methods 0.000 description 24
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 23
240000004808 Saccharomyces cerevisiae Species 0.000 description 23
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 23
241000699666 Mus <mouse, genus> Species 0.000 description 22
239000011324 bead Substances 0.000 description 22
239000003153 chemical reaction reagent Substances 0.000 description 22
108020004999 messenger RNA Proteins 0.000 description 21
108091032973 (ribonucleotides)n+m Proteins 0.000 description 20
102000004127 Cytokines Human genes 0.000 description 20
108090000695 Cytokines Proteins 0.000 description 20
238000001727 in vivo Methods 0.000 description 19
238000011534 incubation Methods 0.000 description 19
239000000427 antigen Substances 0.000 description 18
108091007433 antigens Proteins 0.000 description 18
102000036639 antigens Human genes 0.000 description 18
238000007796 conventional method Methods 0.000 description 17
108091006020 Fc-tagged proteins Proteins 0.000 description 16
230000003013 cytotoxicity Effects 0.000 description 16
231100000135 cytotoxicity Toxicity 0.000 description 16
230000003993 interaction Effects 0.000 description 16
238000000746 purification Methods 0.000 description 16
238000003752 polymerase chain reaction Methods 0.000 description 15
241001529936 Murinae Species 0.000 description 14
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
241000283707 Capra Species 0.000 description 13
239000007790 solid phase Substances 0.000 description 13
238000006467 substitution reaction Methods 0.000 description 13
238000004458 analytical method Methods 0.000 description 12
230000004927 fusion Effects 0.000 description 12
239000002609 medium Substances 0.000 description 12
239000012528 membrane Substances 0.000 description 12
108010002350 Interleukin-2 Proteins 0.000 description 11
102000000588 Interleukin-2 Human genes 0.000 description 11
238000003776 cleavage reaction Methods 0.000 description 11
108091008146 restriction endonucleases Proteins 0.000 description 11
230000007017 scission Effects 0.000 description 11
230000015572 biosynthetic process Effects 0.000 description 10
239000003795 chemical substances by application Substances 0.000 description 10
208000035475 disorder Diseases 0.000 description 10
102000005962 receptors Human genes 0.000 description 10
108020003175 receptors Proteins 0.000 description 10
238000011160 research Methods 0.000 description 10
239000011734 sodium Substances 0.000 description 10
239000000758 substrate Substances 0.000 description 10
108090001008 Avidin Proteins 0.000 description 9
108010022394 Threonine synthase Proteins 0.000 description 9
230000000692 anti-sense effect Effects 0.000 description 9
239000000872 buffer Substances 0.000 description 9
102000004419 dihydrofolate reductase Human genes 0.000 description 9
210000004408 hybridoma Anatomy 0.000 description 9
239000011159 matrix material Substances 0.000 description 9
239000000047 product Substances 0.000 description 9
229940124597 therapeutic agent Drugs 0.000 description 9
230000003612 virological effect Effects 0.000 description 9
241000894006 Bacteria Species 0.000 description 8
102000014914 Carrier Proteins Human genes 0.000 description 8
102000004190 Enzymes Human genes 0.000 description 8
108090000790 Enzymes Proteins 0.000 description 8
102000004388 Interleukin-4 Human genes 0.000 description 8
241000699670 Mus sp. Species 0.000 description 8
239000002253 acid Substances 0.000 description 8
108091008324 binding proteins Proteins 0.000 description 8
230000001472 cytotoxic effect Effects 0.000 description 8
238000005516 engineering process Methods 0.000 description 8
238000000338 in vitro Methods 0.000 description 8
238000006384 oligomerization reaction Methods 0.000 description 8
238000000159 protein binding assay Methods 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
235000002374 tyrosine Nutrition 0.000 description 8
108091026890 Coding region Proteins 0.000 description 7
241000588724 Escherichia coli Species 0.000 description 7
241000701044 Human gammaherpesvirus 4 Species 0.000 description 7
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 7
238000000636 Northern blotting Methods 0.000 description 7
108060008682 Tumor Necrosis Factor Proteins 0.000 description 7
239000000074 antisense oligonucleotide Substances 0.000 description 7
238000012230 antisense oligonucleotides Methods 0.000 description 7
230000001086 cytosolic effect Effects 0.000 description 7
230000002068 genetic effect Effects 0.000 description 7
238000009396 hybridization Methods 0.000 description 7
210000005105 peripheral blood lymphocyte Anatomy 0.000 description 7
230000026731 phosphorylation Effects 0.000 description 7
238000006366 phosphorylation reaction Methods 0.000 description 7
239000013612 plasmid Substances 0.000 description 7
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 7
239000000126 substance Substances 0.000 description 7
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 6
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
-1 IFN-a/p Proteins 0.000 description 6
102000003812 Interleukin-15 Human genes 0.000 description 6
108090000172 Interleukin-15 Proteins 0.000 description 6
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 6
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 6
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 6
102100040247 Tumor necrosis factor Human genes 0.000 description 6
241000700605 Viruses Species 0.000 description 6
238000007792 addition Methods 0.000 description 6
230000000890 antigenic effect Effects 0.000 description 6
230000005754 cellular signaling Effects 0.000 description 6
238000012875 competitive assay Methods 0.000 description 6
238000004590 computer program Methods 0.000 description 6
231100000433 cytotoxic Toxicity 0.000 description 6
238000012217 deletion Methods 0.000 description 6
230000037430 deletion Effects 0.000 description 6
229940079593 drug Drugs 0.000 description 6
238000002474 experimental method Methods 0.000 description 6
125000000524 functional group Chemical group 0.000 description 6
230000005764 inhibitory process Effects 0.000 description 6
239000003550 marker Substances 0.000 description 6
238000010369 molecular cloning Methods 0.000 description 6
108700002791 mouse Cd244a Proteins 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
230000001105 regulatory effect Effects 0.000 description 6
230000010076 replication Effects 0.000 description 6
239000000243 solution Substances 0.000 description 6
230000004083 survival effect Effects 0.000 description 6
238000001890 transfection Methods 0.000 description 6
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 6
238000001262 western blot Methods 0.000 description 6
108020000948 Antisense Oligonucleotides Proteins 0.000 description 5
238000002965 ELISA Methods 0.000 description 5
102000014158 Interleukin-12 Subunit p40 Human genes 0.000 description 5
108010011429 Interleukin-12 Subunit p40 Proteins 0.000 description 5
230000004988 N-glycosylation Effects 0.000 description 5
108010007127 Pulmonary Surfactant-Associated Protein D Proteins 0.000 description 5
102100027845 Pulmonary surfactant-associated protein D Human genes 0.000 description 5
108020004511 Recombinant DNA Proteins 0.000 description 5
208000036142 Viral infection Diseases 0.000 description 5
150000007513 acids Chemical class 0.000 description 5
238000013461 design Methods 0.000 description 5
230000013595 glycosylation Effects 0.000 description 5
238000006206 glycosylation reaction Methods 0.000 description 5
230000002209 hydrophobic effect Effects 0.000 description 5
238000003780 insertion Methods 0.000 description 5
230000037431 insertion Effects 0.000 description 5
239000000463 material Substances 0.000 description 5
108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 description 5
102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 description 5
238000003127 radioimmunoassay Methods 0.000 description 5
210000004988 splenocyte Anatomy 0.000 description 5
230000014616 translation Effects 0.000 description 5
230000009385 viral infection Effects 0.000 description 5
229920002307 Dextran Polymers 0.000 description 4
108010087819 Fc receptors Proteins 0.000 description 4
102000009109 Fc receptors Human genes 0.000 description 4
241000238631 Hexapoda Species 0.000 description 4
108091054437 MHC class I family Proteins 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
241001494479 Pecora Species 0.000 description 4
239000002202 Polyethylene glycol Substances 0.000 description 4
241000700159 Rattus Species 0.000 description 4
101710120037 Toxin CcdB Proteins 0.000 description 4
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
238000001042 affinity chromatography Methods 0.000 description 4
230000000903 blocking effect Effects 0.000 description 4
230000001413 cellular effect Effects 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
238000004587 chromatography analysis Methods 0.000 description 4
239000012504 chromatography matrix Substances 0.000 description 4
238000010367 cloning Methods 0.000 description 4
238000010276 construction Methods 0.000 description 4
230000000875 corresponding effect Effects 0.000 description 4
230000016396 cytokine production Effects 0.000 description 4
230000009089 cytolysis Effects 0.000 description 4
238000001514 detection method Methods 0.000 description 4
201000010099 disease Diseases 0.000 description 4
239000012636 effector Substances 0.000 description 4
239000002158 endotoxin Substances 0.000 description 4
239000003623 enhancer Substances 0.000 description 4
238000000684 flow cytometry Methods 0.000 description 4
230000000799 fusogenic effect Effects 0.000 description 4
239000000499 gel Substances 0.000 description 4
230000012010 growth Effects 0.000 description 4
239000001963 growth medium Substances 0.000 description 4
230000001900 immune effect Effects 0.000 description 4
230000028993 immune response Effects 0.000 description 4
238000000099 in vitro assay Methods 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
230000003834 intracellular effect Effects 0.000 description 4
150000002632 lipids Chemical class 0.000 description 4
238000004949 mass spectrometry Methods 0.000 description 4
210000001616 monocyte Anatomy 0.000 description 4
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 4
229920001223 polyethylene glycol Polymers 0.000 description 4
238000012545 processing Methods 0.000 description 4
238000003259 recombinant expression Methods 0.000 description 4
230000019491 signal transduction Effects 0.000 description 4
241000894007 species Species 0.000 description 4
239000000725 suspension Substances 0.000 description 4
238000011282 treatment Methods 0.000 description 4
210000004881 tumor cell Anatomy 0.000 description 4
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
102000007469 Actins Human genes 0.000 description 3
108010085238 Actins Proteins 0.000 description 3
229920000936 Agarose Polymers 0.000 description 3
102100034044 All-trans-retinol dehydrogenase [NAD(+)] ADH1B Human genes 0.000 description 3
101710193111 All-trans-retinol dehydrogenase [NAD(+)] ADH4 Proteins 0.000 description 3
101001007681 Candida albicans (strain WO-1) Kexin Proteins 0.000 description 3
208000033816 Chronic lymphoproliferative disorder of natural killer cells Diseases 0.000 description 3
108020004635 Complementary DNA Proteins 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
206010015108 Epstein-Barr virus infection Diseases 0.000 description 3
108010001515 Galectin 4 Proteins 0.000 description 3
102100039556 Galectin-4 Human genes 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 3
241000282412 Homo Species 0.000 description 3
108060003951 Immunoglobulin Proteins 0.000 description 3
102000014150 Interferons Human genes 0.000 description 3
108010050904 Interferons Proteins 0.000 description 3
102000010789 Interleukin-2 Receptors Human genes 0.000 description 3
108010038453 Interleukin-2 Receptors Proteins 0.000 description 3
108090001007 Interleukin-8 Proteins 0.000 description 3
206010025323 Lymphomas Diseases 0.000 description 3
241000124008 Mammalia Species 0.000 description 3
101100181099 Mus musculus Klra1 gene Proteins 0.000 description 3
230000006051 NK cell activation Effects 0.000 description 3
108091005804 Peptidases Proteins 0.000 description 3
108091000080 Phosphotransferase Proteins 0.000 description 3
206010035226 Plasma cell myeloma Diseases 0.000 description 3
239000004365 Protease Substances 0.000 description 3
239000012980 RPMI-1640 medium Substances 0.000 description 3
230000024932 T cell mediated immunity Effects 0.000 description 3
230000001270 agonistic effect Effects 0.000 description 3
230000004075 alteration Effects 0.000 description 3
125000000539 amino acid group Chemical group 0.000 description 3
229960000723 ampicillin Drugs 0.000 description 3
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
210000004102 animal cell Anatomy 0.000 description 3
230000008901 benefit Effects 0.000 description 3
229960002685 biotin Drugs 0.000 description 3
235000020958 biotin Nutrition 0.000 description 3
239000011616 biotin Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000004899 c-terminal region Anatomy 0.000 description 3
238000004364 calculation method Methods 0.000 description 3
150000001720 carbohydrates Chemical class 0.000 description 3
239000013592 cell lysate Substances 0.000 description 3
239000013522 chelant Substances 0.000 description 3
230000009920 chelation Effects 0.000 description 3
208000014620 chronic lymphoproliferative disorder of NK-cells Diseases 0.000 description 3
238000004440 column chromatography Methods 0.000 description 3
230000004940 costimulation Effects 0.000 description 3
230000007123 defense Effects 0.000 description 3
239000010432 diamond Substances 0.000 description 3
239000000539 dimer Substances 0.000 description 3
231100000673 dose–response relationship Toxicity 0.000 description 3
238000001976 enzyme digestion Methods 0.000 description 3
235000013861 fat-free Nutrition 0.000 description 3
238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
230000006870 function Effects 0.000 description 3
239000008103 glucose Substances 0.000 description 3
230000036039 immunity Effects 0.000 description 3
230000005847 immunogenicity Effects 0.000 description 3
102000018358 immunoglobulin Human genes 0.000 description 3
230000000415 inactivating effect Effects 0.000 description 3
230000002452 interceptive effect Effects 0.000 description 3
238000001990 intravenous administration Methods 0.000 description 3
238000002955 isolation Methods 0.000 description 3
125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
208000032839 leukemia Diseases 0.000 description 3
229910052751 metal Inorganic materials 0.000 description 3
239000002184 metal Substances 0.000 description 3
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 3
239000004005 microsphere Substances 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
201000000050 myeloid neoplasm Diseases 0.000 description 3
238000004091 panning Methods 0.000 description 3
210000005259 peripheral blood Anatomy 0.000 description 3
239000011886 peripheral blood Substances 0.000 description 3
102000020233 phosphotransferase Human genes 0.000 description 3
230000008488 polyadenylation Effects 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
239000011347 resin Substances 0.000 description 3
229920005989 resin Polymers 0.000 description 3
230000000284 resting effect Effects 0.000 description 3
238000004007 reversed phase HPLC Methods 0.000 description 3
206010039073 rheumatoid arthritis Diseases 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
238000013391 scatchard analysis Methods 0.000 description 3
239000006152 selective media Substances 0.000 description 3
238000012163 sequencing technique Methods 0.000 description 3
239000007787 solid Substances 0.000 description 3
230000009870 specific binding Effects 0.000 description 3
210000004989 spleen cell Anatomy 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
239000003053 toxin Substances 0.000 description 3
231100000765 toxin Toxicity 0.000 description 3
108700012359 toxins Proteins 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000002103 transcriptional effect Effects 0.000 description 3
238000010361 transduction Methods 0.000 description 3
230000026683 transduction Effects 0.000 description 3
238000013519 translation Methods 0.000 description 3
PZYFJWVGRGEWGO-UHFFFAOYSA-N trisodium;hydrogen peroxide;trioxido(oxo)vanadium Chemical compound [Na+].[Na+].[Na+].OO.OO.OO.[O-][V]([O-])([O-])=O PZYFJWVGRGEWGO-UHFFFAOYSA-N 0.000 description 3
241001430294 unidentified retrovirus Species 0.000 description 3
102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 2
229930024421 Adenine Natural products 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
229920001817 Agar Polymers 0.000 description 2
JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 description 2
208000002109 Argyria Diseases 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
208000023275 Autoimmune disease Diseases 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
125000001433 C-terminal amino-acid group Chemical group 0.000 description 2
210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 2
101150023971 Cd48 gene Proteins 0.000 description 2
102000000844 Cell Surface Receptors Human genes 0.000 description 2
108010001857 Cell Surface Receptors Proteins 0.000 description 2
241000282552 Chlorocebus aethiops Species 0.000 description 2
241000701022 Cytomegalovirus Species 0.000 description 2
102000052510 DNA-Binding Proteins Human genes 0.000 description 2
230000004568 DNA-binding Effects 0.000 description 2
102100031132 Glucose-6-phosphate isomerase Human genes 0.000 description 2
108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 2
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
239000007995 HEPES buffer Substances 0.000 description 2
241000701109 Human adenovirus 2 Species 0.000 description 2
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
102000000589 Interleukin-1 Human genes 0.000 description 2
108010002352 Interleukin-1 Proteins 0.000 description 2
102000019223 Interleukin-1 receptor Human genes 0.000 description 2
108050006617 Interleukin-1 receptor Proteins 0.000 description 2
108010002386 Interleukin-3 Proteins 0.000 description 2
102000000646 Interleukin-3 Human genes 0.000 description 2
102100021592 Interleukin-7 Human genes 0.000 description 2
108010002586 Interleukin-7 Proteins 0.000 description 2
108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 2
101150045458 KEX2 gene Proteins 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
208000030289 Lymphoproliferative disease Diseases 0.000 description 2
NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 2
NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 description 2
102000043129 MHC class I family Human genes 0.000 description 2
102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
101000716129 Mus musculus CD48 antigen Proteins 0.000 description 2
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
125000000729 N-terminal amino-acid group Chemical group 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
101710163270 Nuclease Proteins 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
102000000447 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Human genes 0.000 description 2
108010055817 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Proteins 0.000 description 2
239000013614 RNA sample Substances 0.000 description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
238000002105 Southern blotting Methods 0.000 description 2
108091081024 Start codon Proteins 0.000 description 2
230000006044 T cell activation Effects 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
206010052779 Transplant rejections Diseases 0.000 description 2
101710100170 Unknown protein Proteins 0.000 description 2
108010067390 Viral Proteins Proteins 0.000 description 2
MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 2
239000011149 active material Substances 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
239000008272 agar Substances 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
230000003042 antagnostic effect Effects 0.000 description 2
108010062796 arginyllysine Proteins 0.000 description 2
206010003246 arthritis Diseases 0.000 description 2
230000003190 augmentative effect Effects 0.000 description 2
238000000376 autoradiography Methods 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
230000001588 bifunctional effect Effects 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
229940098773 bovine serum albumin Drugs 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
230000003185 calcium uptake Effects 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
239000000969 carrier Substances 0.000 description 2
150000001768 cations Chemical class 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
230000004663 cell proliferation Effects 0.000 description 2
230000015861 cell surface binding Effects 0.000 description 2
230000033077 cellular process Effects 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
229940127089 cytotoxic agent Drugs 0.000 description 2
239000002254 cytotoxic agent Substances 0.000 description 2
231100000599 cytotoxic agent Toxicity 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000002950 deficient Effects 0.000 description 2
229940124447 delivery agent Drugs 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
239000000032 diagnostic agent Substances 0.000 description 2
229940039227 diagnostic agent Drugs 0.000 description 2
229910003460 diamond Inorganic materials 0.000 description 2
230000029087 digestion Effects 0.000 description 2
238000010494 dissociation reaction Methods 0.000 description 2
230000005593 dissociations Effects 0.000 description 2
238000009510 drug design Methods 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
CTSPAMFJBXKSOY-UHFFFAOYSA-N ellipticine Chemical compound N1=CC=C2C(C)=C(NC=3C4=CC=CC=3)C4=C(C)C2=C1 CTSPAMFJBXKSOY-UHFFFAOYSA-N 0.000 description 2
210000002919 epithelial cell Anatomy 0.000 description 2
238000009472 formulation Methods 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
125000003147 glycosyl group Chemical group 0.000 description 2
210000005260 human cell Anatomy 0.000 description 2
230000002998 immunogenetic effect Effects 0.000 description 2
239000012133 immunoprecipitate Substances 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
230000000266 injurious effect Effects 0.000 description 2
229940076264 interleukin-3 Drugs 0.000 description 2
229940100994 interleukin-7 Drugs 0.000 description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
229960000310 isoleucine Drugs 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
210000003292 kidney cell Anatomy 0.000 description 2
230000002147 killing effect Effects 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
239000006166 lysate Substances 0.000 description 2
108010054155 lysyllysine Proteins 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
238000000386 microscopy Methods 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
230000009871 nonspecific binding Effects 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
210000001672 ovary Anatomy 0.000 description 2
230000037361 pathway Effects 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
235000008476 powdered milk Nutrition 0.000 description 2
230000037452 priming Effects 0.000 description 2
230000008569 process Effects 0.000 description 2
230000012846 protein folding Effects 0.000 description 2
238000001742 protein purification Methods 0.000 description 2
230000007115 recruitment Effects 0.000 description 2
230000004043 responsiveness Effects 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
210000003705 ribosome Anatomy 0.000 description 2
238000007790 scraping Methods 0.000 description 2
238000000926 separation method Methods 0.000 description 2
238000013207 serial dilution Methods 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
230000011664 signaling Effects 0.000 description 2
230000007781 signaling event Effects 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
210000000952 spleen Anatomy 0.000 description 2
230000002269 spontaneous effect Effects 0.000 description 2
230000006641 stabilisation Effects 0.000 description 2
238000011105 stabilization Methods 0.000 description 2
238000010186 staining Methods 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
238000004448 titration Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
238000012546 transfer Methods 0.000 description 2
230000009466 transformation Effects 0.000 description 2
239000013638 trimer Substances 0.000 description 2
238000005829 trimerization reaction Methods 0.000 description 2
150000003668 tyrosines Chemical class 0.000 description 2
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
229940035893 uracil Drugs 0.000 description 2
238000011179 visual inspection Methods 0.000 description 2
238000012800 visualization Methods 0.000 description 2
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
FJQZXCPWAGYPSD-UHFFFAOYSA-N 1,3,4,6-tetrachloro-3a,6a-diphenylimidazo[4,5-d]imidazole-2,5-dione Chemical compound ClN1C(=O)N(Cl)C2(C=3C=CC=CC=3)N(Cl)C(=O)N(Cl)C12C1=CC=CC=C1 FJQZXCPWAGYPSD-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
108010066676 Abrin Proteins 0.000 description 1
241001556567 Acanthamoeba polyphaga mimivirus Species 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
206010000830 Acute leukaemia Diseases 0.000 description 1
208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
YCRAFFCYWOUEOF-DLOVCJGASA-N Ala-Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 YCRAFFCYWOUEOF-DLOVCJGASA-N 0.000 description 1
HOVPGJUNRLMIOZ-CIUDSAMLSA-N Ala-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N HOVPGJUNRLMIOZ-CIUDSAMLSA-N 0.000 description 1
108020005544 Antisense RNA Proteins 0.000 description 1
101100107610 Arabidopsis thaliana ABCF4 gene Proteins 0.000 description 1
OMLWNBVRVJYMBQ-YUMQZZPRSA-N Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OMLWNBVRVJYMBQ-YUMQZZPRSA-N 0.000 description 1
NYDIVDKTULRINZ-AVGNSLFASA-N Arg-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N NYDIVDKTULRINZ-AVGNSLFASA-N 0.000 description 1
230000003844 B-cell-activation Effects 0.000 description 1
102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 1
208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
206010048396 Bone marrow transplant rejection Diseases 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108700031361 Brachyury Proteins 0.000 description 1
101710186200 CCAAT/enhancer-binding protein Proteins 0.000 description 1
102100032912 CD44 antigen Human genes 0.000 description 1
108010084313 CD58 Antigens Proteins 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
238000011537 Coomassie blue staining Methods 0.000 description 1
241000711573 Coronaviridae Species 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
108020003215 DNA Probes Proteins 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
108700020911 DNA-Binding Proteins Proteins 0.000 description 1
101710096438 DNA-binding protein Proteins 0.000 description 1
102000016607 Diphtheria Toxin Human genes 0.000 description 1
108010053187 Diphtheria Toxin Proteins 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
108010031111 EBV-encoded nuclear antigen 1 Proteins 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
101710122227 Epstein-Barr nuclear antigen 1 Proteins 0.000 description 1
241000283086 Equidae Species 0.000 description 1
XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
206010071602 Genetic polymorphism Diseases 0.000 description 1
YYOBUPFZLKQUAX-FXQIFTODSA-N Glu-Asn-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YYOBUPFZLKQUAX-FXQIFTODSA-N 0.000 description 1
HJIFPJUEOGZWRI-GUBZILKMSA-N Glu-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N HJIFPJUEOGZWRI-GUBZILKMSA-N 0.000 description 1
KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 1
102000030595 Glucokinase Human genes 0.000 description 1
DHDOADIPGZTAHT-YUMQZZPRSA-N Gly-Glu-Arg Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DHDOADIPGZTAHT-YUMQZZPRSA-N 0.000 description 1
ZIXGXMMUKPLXBB-UHFFFAOYSA-N Guatambuinine Natural products N1C2=CC=CC=C2C2=C1C(C)=C1C=CN=C(C)C1=C2 ZIXGXMMUKPLXBB-UHFFFAOYSA-N 0.000 description 1
102000000039 Heat Shock Transcription Factor Human genes 0.000 description 1
108050008339 Heat Shock Transcription Factor Proteins 0.000 description 1
241000711557 Hepacivirus Species 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
208000007514 Herpes zoster Diseases 0.000 description 1
102000005548 Hexokinase Human genes 0.000 description 1
108700040460 Hexokinases Proteins 0.000 description 1
MMFKFJORZBJVNF-UWVGGRQHSA-N His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 MMFKFJORZBJVNF-UWVGGRQHSA-N 0.000 description 1
108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 1
101000919320 Homo sapiens Adapter molecule crk Proteins 0.000 description 1
101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 1
101100059511 Homo sapiens CD40LG gene Proteins 0.000 description 1
101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
101001033233 Homo sapiens Interleukin-10 Proteins 0.000 description 1
101001002709 Homo sapiens Interleukin-4 Proteins 0.000 description 1
101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 1
101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 1
101000633778 Homo sapiens SLAM family member 5 Proteins 0.000 description 1
241000701024 Human betaherpesvirus 5 Species 0.000 description 1
GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
108700001097 Insect Genes Proteins 0.000 description 1
102000010787 Interleukin-4 Receptors Human genes 0.000 description 1
108010038486 Interleukin-4 Receptors Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
102000002698 KIR Receptors Human genes 0.000 description 1
108010043610 KIR Receptors Proteins 0.000 description 1
241000235649 Kluyveromyces Species 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
238000011050 LAL assay Methods 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
108090001090 Lectins Proteins 0.000 description 1
102000004856 Lectins Human genes 0.000 description 1
AMSSKPUHBUQBOQ-SRVKXCTJSA-N Leu-Ser-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N AMSSKPUHBUQBOQ-SRVKXCTJSA-N 0.000 description 1
102000004882 Lipase Human genes 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
239000004367 Lipase Substances 0.000 description 1
102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 1
HVAUKHLDSDDROB-KKUMJFAQSA-N Lys-Lys-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HVAUKHLDSDDROB-KKUMJFAQSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
241000712079 Measles morbillivirus Species 0.000 description 1
102000012750 Membrane Glycoproteins Human genes 0.000 description 1
108010090054 Membrane Glycoproteins Proteins 0.000 description 1
102000005741 Metalloproteases Human genes 0.000 description 1
108010006035 Metalloproteases Proteins 0.000 description 1
102000003792 Metallothionein Human genes 0.000 description 1
108090000157 Metallothionein Proteins 0.000 description 1
108700005443 Microbial Genes Proteins 0.000 description 1
102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 1
231100000678 Mycotoxin Toxicity 0.000 description 1
208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
108091008877 NK cell receptors Proteins 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
102000010648 Natural Killer Cell Receptors Human genes 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
102000043276 Oncogene Human genes 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
108010087702 Penicillinase Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
239000001888 Peptone Substances 0.000 description 1
108010080698 Peptones Proteins 0.000 description 1
108010056995 Perforin Proteins 0.000 description 1
KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 description 1
102000001105 Phosphofructokinases Human genes 0.000 description 1
108010069341 Phosphofructokinases Proteins 0.000 description 1
102000011420 Phospholipase D Human genes 0.000 description 1
108090000553 Phospholipase D Proteins 0.000 description 1
102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
241000218657 Picea Species 0.000 description 1
241000235648 Pichia Species 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
241001505332 Polyomavirus sp. Species 0.000 description 1
208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
XUSDDSLCRPUKLP-QXEWZRGKSA-N Pro-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 XUSDDSLCRPUKLP-QXEWZRGKSA-N 0.000 description 1
102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 1
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
208000010362 Protozoan Infections Diseases 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
101900161471 Pseudomonas aeruginosa Exotoxin A Proteins 0.000 description 1
108010011939 Pyruvate Decarboxylase Proteins 0.000 description 1
108020005115 Pyruvate Kinase Proteins 0.000 description 1
102000013009 Pyruvate Kinase Human genes 0.000 description 1
239000012083 RIPA buffer Substances 0.000 description 1
108020004518 RNA Probes Proteins 0.000 description 1
239000003391 RNA probe Substances 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
108010039491 Ricin Proteins 0.000 description 1
238000011579 SCID mouse model Methods 0.000 description 1
102000014400 SH2 domains Human genes 0.000 description 1
108050003452 SH2 domains Proteins 0.000 description 1
SUYXJDLXGFPMCQ-INIZCTEOSA-N SJ000287331 Natural products CC1=c2cnccc2=C(C)C2=Nc3ccccc3[C@H]12 SUYXJDLXGFPMCQ-INIZCTEOSA-N 0.000 description 1
241000235070 Saccharomyces Species 0.000 description 1
101100068078 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GCN4 gene Proteins 0.000 description 1
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
101800001707 Spacer peptide Proteins 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
102000014384 Type C Phospholipases Human genes 0.000 description 1
108010079194 Type C Phospholipases Proteins 0.000 description 1
ZQOOYCZQENFIMC-STQMWFEESA-N Tyr-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CC=C(O)C=C1 ZQOOYCZQENFIMC-STQMWFEESA-N 0.000 description 1
XGJLNBNZNMVJRS-NRPADANISA-N Val-Glu-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O XGJLNBNZNMVJRS-NRPADANISA-N 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical group [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
238000006843 Zinner synthesis reaction Methods 0.000 description 1
WPWCLBXYKATSMD-UHFFFAOYSA-N [2-(tert-butylcarbamoylamino)-2-oxoethyl] 3-cyclopentylpropanoate Chemical compound CC(C)(C)NC(=O)NC(=O)COC(=O)CCC1CCCC1 WPWCLBXYKATSMD-UHFFFAOYSA-N 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
230000009471 action Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
238000000787 affinity precipitation Methods 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
238000013019 agitation Methods 0.000 description 1
239000002168 alkylating agent Substances 0.000 description 1
229940100198 alkylating agent Drugs 0.000 description 1
KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
239000003957 anion exchange resin Substances 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 1
210000000612 antigen-presenting cell Anatomy 0.000 description 1
238000013459 approach Methods 0.000 description 1
108010068380 arginylarginine Proteins 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
230000001651 autotrophic effect Effects 0.000 description 1
150000001540 azides Chemical class 0.000 description 1
108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
239000012148 binding buffer Substances 0.000 description 1
238000002306 biochemical method Methods 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000002051 biphasic effect Effects 0.000 description 1
230000037396 body weight Effects 0.000 description 1
239000008366 buffered solution Substances 0.000 description 1
RICLFGYGYQXUFH-UHFFFAOYSA-N buspirone hydrochloride Chemical compound [H+].[Cl-].C1C(=O)N(CCCCN2CCN(CC2)C=2N=CC=CN=2)C(=O)CC21CCCC2 RICLFGYGYQXUFH-UHFFFAOYSA-N 0.000 description 1
238000004422 calculation algorithm Methods 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
238000005341 cation exchange Methods 0.000 description 1
230000022534 cell killing Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000004715 cellular signal transduction Effects 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
235000013330 chicken meat Nutrition 0.000 description 1
238000011098 chromatofocusing Methods 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
238000000749 co-immunoprecipitation Methods 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
229940047120 colony stimulating factors Drugs 0.000 description 1
238000009096 combination chemotherapy Methods 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
210000004395 cytoplasmic granule Anatomy 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000005860 defense response to virus Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
210000000940 dendritic epidermal T lymphocyte Anatomy 0.000 description 1
229940009976 deoxycholate Drugs 0.000 description 1
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
238000001212 derivatisation Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
238000006471 dimerization reaction Methods 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
238000009826 distribution Methods 0.000 description 1
230000007783 downstream signaling Effects 0.000 description 1
238000001378 electrochemiluminescence detection Methods 0.000 description 1
230000009881 electrostatic interaction Effects 0.000 description 1
238000005421 electrostatic potential Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
239000012149 elution buffer Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
230000007515 enzymatic degradation Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
210000003617 erythrocyte membrane Anatomy 0.000 description 1
239000013613 expression plasmid Substances 0.000 description 1
239000012847 fine chemical Substances 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
230000002414 glycolytic effect Effects 0.000 description 1
229930004094 glycosylphosphatidylinositol Natural products 0.000 description 1
210000003714 granulocyte Anatomy 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
230000003394 haemopoietic effect Effects 0.000 description 1
210000002216 heart Anatomy 0.000 description 1
230000002607 hemopoietic effect Effects 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
239000000833 heterodimer Substances 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
108010025306 histidylleucine Proteins 0.000 description 1
102000049411 human CD84 Human genes 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
125000001165 hydrophobic group Chemical group 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
229940097277 hygromycin b Drugs 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
238000003119 immunoblot Methods 0.000 description 1
238000000760 immunoelectrophoresis Methods 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
230000002637 immunotoxin Effects 0.000 description 1
239000002596 immunotoxin Substances 0.000 description 1
231100000608 immunotoxin Toxicity 0.000 description 1
229940051026 immunotoxin Drugs 0.000 description 1
239000007943 implant Substances 0.000 description 1
239000000411 inducer Substances 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
108091008042 inhibitory receptors Proteins 0.000 description 1
208000014674 injury Diseases 0.000 description 1
210000005007 innate immune system Anatomy 0.000 description 1
239000000138 intercalating agent Substances 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
229940047124 interferons Drugs 0.000 description 1
230000004073 interleukin-2 production Effects 0.000 description 1
230000016507 interphase Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
238000001155 isoelectric focusing Methods 0.000 description 1
125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000002523 lectin Substances 0.000 description 1
235000019421 lipase Nutrition 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
239000002502 liposome Substances 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
208000003747 lymphoid leukemia Diseases 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
238000013507 mapping Methods 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
229910021645 metal ion Inorganic materials 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
239000000693 micelle Substances 0.000 description 1
239000004530 micro-emulsion Substances 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 description 1
210000005087 mononuclear cell Anatomy 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
230000035772 mutation Effects 0.000 description 1
108700024542 myc Genes Proteins 0.000 description 1
239000002636 mycotoxin Substances 0.000 description 1
VELGMVLNORPMAO-JTFNWEOFSA-N n-[(e)-1-[(3r,4r,5s,6r)-5-[(2s,3r,4r,5r,6r)-5-[(2s,3r,4r,5r,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxym Chemical compound O[C@@H]1[C@@H](O)C(OCC(NC(=O)CCCCCCCCCCCCCCCCC)C(O)\C=C\CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)O1 VELGMVLNORPMAO-JTFNWEOFSA-N 0.000 description 1
230000031942 natural killer cell mediated cytotoxicity Effects 0.000 description 1
239000013642 negative control Substances 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
230000003606 oligomerizing effect Effects 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
238000012856 packing Methods 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
229950009506 penicillinase Drugs 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
235000019319 peptone Nutrition 0.000 description 1
229930192851 perforin Natural products 0.000 description 1
210000004976 peripheral blood cell Anatomy 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
108010064607 phosphoglucokinase Proteins 0.000 description 1
150000003906 phosphoinositides Chemical class 0.000 description 1
230000006461 physiological response Effects 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920009537 polybutylene succinate adipate Polymers 0.000 description 1
239000004633 polyglycolic acid Substances 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000002952 polymeric resin Substances 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
230000001323 posttranslational effect Effects 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000002028 premature Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000009696 proliferative response Effects 0.000 description 1
210000002307 prostate Anatomy 0.000 description 1
108020000494 protein-tyrosine phosphatase Proteins 0.000 description 1
230000004850 protein–protein interaction Effects 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
238000000275 quality assurance Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000000163 radioactive labelling Methods 0.000 description 1
238000003156 radioimmunoprecipitation Methods 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
238000011084 recovery Methods 0.000 description 1
238000004153 renaturation Methods 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
239000007320 rich medium Substances 0.000 description 1
238000005185 salting out Methods 0.000 description 1
238000009738 saturating Methods 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
238000002864 sequence alignment Methods 0.000 description 1
239000013605 shuttle vector Substances 0.000 description 1
230000007727 signaling mechanism Effects 0.000 description 1
230000037432 silent mutation Effects 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
238000001542 size-exclusion chromatography Methods 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
239000002904 solvent Substances 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
230000003393 splenic effect Effects 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
239000012622 synthetic inhibitor Substances 0.000 description 1
229920003002 synthetic resin Polymers 0.000 description 1
238000004885 tandem mass spectrometry Methods 0.000 description 1
210000001550 testis Anatomy 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
229960001479 tosylchloramide sodium Drugs 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000010474 transient expression Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
229930013292 trichothecene Natural products 0.000 description 1
150000003327 trichothecene derivatives Chemical class 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
230000005909 tumor killing Effects 0.000 description 1
102000003390 tumor necrosis factor Human genes 0.000 description 1
230000007306 turnover Effects 0.000 description 1
238000000108 ultra-filtration Methods 0.000 description 1
230000009452 underexpressoin Effects 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
LSGOVYNHVSXFFJ-UHFFFAOYSA-N vanadate(3-) Chemical compound [O-][V]([O-])([O-])=O LSGOVYNHVSXFFJ-UHFFFAOYSA-N 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
238000002424 x-ray crystallography Methods 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1
238000001086 yeast two-hybrid system Methods 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1